Other informations about the equity market according to article 50 WpHG
QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]
Venlo (pta016/31.05.2024/12:22 UTC+2)
Release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution. Post-admission Duties announcement according to Article 50 Para. 1, No. 2 of the WpHG.
FORM S-8 REGISTRATION STATEMENT
QIAGEN N.V. hereby announces that a Form S-8 Registration Statement under the securities act of 1933 was filed with the United States Securities and Exchange Commission (SEC).
The document is now available on the website of QIAGEN:
https://s28.q4cdn.com/125951340/files/doc_downloads/other_reports/2024/2024-Form-S-8-Final-as-filed-May-30-2024.pdf
(end)
| Emitter: |
QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands |
|
|---|---|---|
| Contact Person: | Investor Relations | |
| Phone: | +31 7735566 - 00 | |
| E-Mail: | ir@qiagen.com | |
| Website: | www.qiagen.com | |
| ISIN(s): | NL0015001WM6 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate | |
| Other Stock Exchanges: | NYSE, SIX, BX Swiss |